Articles related to SMALL CELL LUNG CANCER (SCLC)
Highlights in Non–Small Cell Lung Cancer from the IASLC 2023 World Conference on Lung Cancer
This review encompasses nine recent studies in oncology, highlighting the application of innovative therapies and drug combinations in the treatment of lung cancer.
Oncology, Medical November 13th 2023
Toripalimab Plus Chemo Dubbed New Standard First-Line Therapy for ES-SCLC
The phase 3 EXTENTORCH trial has demonstrated the potential of toripalimab plus chemotherapy as a new standard first-line therapy for ES-SCLC, with a median progression-free survival of 5.8 months.
Oncology, Medical November 6th 2023
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
This phase 2 trial demonstrated that tarlatamab showed antitumor activity with durable objective responses and promising survival outcomes in patients with previously treated small-cell lung cancer. With a manageable safety profile and no new safety signals identified, tarlatamab could represent a significant advancement in the treatment landscape for these patients.
Oncology, Medical October 23rd 2023
Prophylactic Cranial Irradiation Improved Survival Outcomes Compared to Consolidative Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung Cancer
New research indicates that PCI offers significant survival advantages over TRT in treating extensive-stage small cell lung cancer, challenging existing treatment protocols.
Oncology, Medical October 2nd 2023
Therapy Selection in Small Cell Lung Cancer with Disease Progression After Platinum-Based Therapy
Explore the complexities of treating small cell lung cancer (SCLC) after platinum-based therapy failure, including insights into immune checkpoint inhibitors, the preference for lurbinectedin, and the potential of liquid biopsies. Join Dr. Misty Shields in understanding the challenges and opportunities in this evolving field.
Oncology, Medical August 21st 2023